Outcomes for CrAg-positive patients after the recruitment -The time of virological failure had a media of 31 months, with IQI 5-129.
-15/17 (88.2%) were retention in care, 12/17 (70.5%) at follow up in the original service; 3/17 (17.6%) at follow up other facilities -2/17 (11.7%) died -10 (59%) subjects had the ART changed because of virological failure -6/17 (35.3%) had viral resistance, confirmed by genotyping -6/17 (35.3%) weren't in regular use of ART during the last year of follow up and 1/15 wasn't adherent for the last three months -Preemptive treatment: 9 with fluconazole; 4 with itraconazole and 1treated with amphotericin + fluconazole -11/17 (64.7%) used the recommended treatment for at least 10 weeks 
